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Reducing the growing burden of livestock and zoonotic disease 
under climate change through new evidence, tools and technology 
and improved disease surveillance
ILRI’s objectives 
ILRI will support improved control of livestock disease 
across sub-Saharan Africa and Southeast Asia by providing 
policymakers and animal health professionals with new 
evidence, tools and technology that enable them to 
successfully address the growing and shifting burden of 
livestock disease under climate change. Outcomes include:  
• Decision makers prioritize diseases and develop and 
deploy effective disease control strategies based on new 
evidence on climate change impacts on livestock and 
human disease.  
• Tools and technical support available to countries to 
improve their disease surveillance and response systems 
in order to detect changes in disease in a timely way, 
thus dramatically reducing the cost of response.  
• No regret adaptation responses for key climate sensitive 
diseases in target geographies, reducing morbidity and 
mortality for livestock and humans.  
• New vaccines and diagnostics for climate sensitive 
diseases in the pipeline, with some ready for deployment 
and commercialization in 2–10 years.  
Situation analysis 
Animal and public health care systems in developing 
countries are poorly equipped to handle the increased 
disease burden driven by climate change. Already 20% of 
ruminants and more than 50% of poultry die prematurely 
each year, causing a loss of USD300 billion per year (Dinesh 
et al. 2015). At least half of these deaths are due to infectious 
diseases. Losses caused by the Rift Valley fever (RVF) outbreak 
that occurred in Kenya in 2006/2007 was estimated at USD32 
million (Rich and Wanyoike 2010). Uganda and Rwanda are 
now reporting incidences of the disease. Trypanosomosis 
costs livestock keepers in East Africa USD2 billion per year 
and East Coast fever (ECF) kills one million animals in Africa 
per year (Dinesh et al. 2015).  
The majority of the animal diseases most important to 
poor livestock keepers are climate sensitive. Changes in 
temperature, precipitation and humidity will vary geographical 
ranges of most of these diseases, cause major shifts in the 
distribution and prevalence of vectors, and increase the 
incidence and intensity of infectious disease epidemics 
(Heffernan 2018; Grace et al. 2015). Temperature changes will 
drive major shifts in tsetse distribution throughout Africa; in 
some geographies it will decline, in others increase (Grace 
et al. 2015). Increased frequency of extreme events such as 
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Regional, national and local organizations need support 
to implement quality surveillance programs in the face 
of shifting disease burden. Well-functioning surveillance 
systems and timely responses may reduce the cost of 
disease outbreaks by 95% (Grace 2014), but official disease 
reporting systems are plagued by massive under-reporting 
and research studies that provide more accurate information 
are often small, unrepresentative and dated. Organizations 
need accurate information on pests and disease presence, 
level, impacts and the costs for control. Impacts are not 
constrained within national boundaries; thus, response 
strategies should develop approaches to coordinate at the 
regional and continental scales. ILRI is working with partners 
in Kenya to roll out new satellite technology to track the 
impact of climate-related shocks on livestock health, such as 
the impacts of heavy flooding on vector-borne disease. This 
and other types of disease surveillance tools can be further 
developed and rolled out for use.  
New technologies targeted at climate sensitive diseases 
could mediate the impacts of climate change on disease 
distribution and incidence. Effective diagnostics, drugs and 
vaccines are lacking for most climate sensitive diseases. In 
cases in which they do exist, high cost, strain specificity, low 
efficacy and lack of availability render them ineffective at 
reducing morbidity and mortality from disease. 
El Niño will drive disease incidence; in eastern Africa, the 
warm phase of El Niño is associated with outbreaks of many 
mosquito-borne diseases including RVF (Anyamba et al. 2009). 
Around 60 percent of all infectious diseases are zoonotic 
through either contact with or the consumption of animal 
products and byproducts (Grace et al. 2012). Food and 
water-borne zoonoses can be highly climate sensitive, putting 
livestock keepers and other populations at increased risk 
(Grace et al. 2015). 
To prioritize, plan and implement against changes in 
disease burden, new analyses are needed to forecast 
more reliable estimates under different climate change 
scenarios. The effect of different futures on livestock 
diseases, especially on non-vector borne diseases, have 
received little attention.  Advances in multi-variate modeling 
approaches, understanding of current disease distribution, 
regional climate projections, agricultural land cover maps, 
improved population maps and projections, and foresight 
analysis enable more systematic analysis of the dynamics of 
disease distribution. Key risks to assess include:  
• Co-location of climate sensitive diseases multiplies 
the disease burden. Numerous climate sensitive 
livestock diseases may occur in common areas given 
that their emergence and transmission are controlled 
by similar ecological factors. The occurrence of a high 
number of diseases can overwhelm both private and 
public health service providers.  
• Endemic diseases shift their range, catching 
producers and health systems unprepared. Local 
geographical shifts in vector-pathogen-host ranges have 
likely occurred in endemic areas, but no investigations 
have been done to demonstrate such changes.  
• Changes in human population and behavior magnify 
the impact of climate change on disease. Land use 
changes that are implemented in response to climate 
change and variability can result in more animal and 
human disease. For example, these changes may result 
in loss of biodiversity, which increases disease risk, and/
or pesticide poisoning of humans as farmers apply more 
pesticides in response to increased tick populations.    
Vaccines and antibiotics may no longer work under 
the pressures of climate change, impacting the design 
of new disease control strategies. Many vaccines and 
antibiotics are more effective when administered to hosts 
that are immunocompetent. Increasing temperatures will 
reduce an animal’s ability to fight off infections. Temperatures 
above 30°C cause a reduction in feed intake and trigger the 
secretion of stress hormones which suppress immunological 
responses. New research is needed to understand which 
disease control technologies will become ineffective with 
climate change. 
Investing in no-regret animal health adaptation responses 
is a win-win for livestock keepers, communities, 
countries and regions. Trypanosomosis, RVF and ECF 
are three of the most serious and most climate sensitive 
animal pests. There are proven disease control methods 
that are highly cost-effective but require investments to 
roll out. Investing in community-based vector control for 
the trypanosomosis vector, risk maps and decision-support 
frameworks for RVF (Oyas et al. 2018; Munyua et al. 2016) 
and continued roll out for the infection and treatment 
‘vaccination’ for ECF (Perry 2016) will have benefits many 
times the cost. Risk maps and decision-support frameworks 
can also be adapted for other climate sensitive diseases.  
Long-term investments in new technology development, 
especially for multivariate and thermostable vaccines that can 
address multiple disease burden and remain effective in the 
face of rising temperatures, are needed for climate sensitive 
diseases important to poor livestock keepers.  
ILRI’s solutions 
Solution 1: Determine climate change impacts on 
livestock and human health now and in the future 
Utilize historical data sets, new in-field and research-station 
surveys and studies, and forecast modeling to conduct 
research in the following areas:  
1. Ground-truth the list of climate sensitive diseases to 
help policymakers, researchers and donors prioritize.  
2. Determine the effect of climate change on multiple 
climate sensitive vectors and pathogens to obtain more 
reliable estimates of disease burden.  
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3. Determine how climate change impacts disease 
transmission through indirect pathways. For example, 
understand the potential land use changes in response to 
climate change and monitor impacts on animal disease to 
allow preventive or remedial actions. 
4. Determine whether the effects of climate change 
on immunological responses in hosts can limit the 
effectiveness of vaccines and drugs, starting with ECF and 
RVF. 
Solution 2: Support local, national and regional surveillance 
for upsurge in the incidence of climate sensitive diseases, 
especially endemic infectious diseases 
1. Work with national governments to deploy standardized 
and systematic monitoring of climate, vectors, pathogens 
and diseases over multiple sites and over a long period of 
time to obtain evidence on the effects of climate change 
on disease distribution in endemically infected areas. 
2. Develop standardized procedures for establishing and 
deploying participatory disease surveillance.  
3. Develop and test innovative technologies for surveillance, 
including mobile phone and internet applications, and more 
rapid methods for processing and analyzing data.  
Solution 3: Develop decision support and use tools to guide 
the deployment of interventions  
1. Develop risk maps and decision support frameworks for 
climate sensitive diseases.  
2. Update recommendations and manuals on tick control 
based on projections of changes in prevalence and tailor 
them to environments and production systems.  
3. Update recommendations and manuals on judicious use 
of trypanocides to control trypanosomosis based on 
projections of changes in prevalence and tailor them to 
particular environments and production systems.  
4. Support the roll out of community-based vector control 
for the trypanosomosis vector through assessments of the 
incentives and economic impacts of different approaches. 
Solution 4: Develop new disease control technologies for 
climate sensitive diseases, including vaccines and diagnostics 
tests, and strategies for their deployment. 
1. Develop vaccines for climate sensitive diseases important 
to the poor.  
• Continue development of the new RVF vaccine that 
will work for both humans and animals, 
opening up unique delivery pathways.  
• Continue development of the ECF sub-unit 
vaccine, currently in proof-of-concept stage 
with approximately five years to deployment, 
which will be more sustainable than the 
currently available technology because it is 
thermostable and less expensive.  
• Develop new multivalent vaccines that can 
confer immunity to multiple diseases.  
• Develop thermo-tolerant vaccines that do not 
require cold-chain. 
2. Develop diagnostics for climate sensitive diseases 
important to the poor including a rapid test kit for 
RVF, a diagnostic kit for cysticercosis and multiplex 
diagnostics for bundles of climate sensitive 
diseases.  
3. Develop use manuals for the new technologies, 
including how to deploy in specific production 
systems and within a population of animals, 
community of producers and countries/regions.  
4. Work with public and private sector partners 
to develop manufacturing, commercialization 
(when appropriate) and roll out plans for each 
technology.  
Roll out ready tools: Risk maps 
and decision support tools for 
Rift Valley fever and other climate 
sensitive diseases  
ILRI will work with national stakeholders in Uganda 
and Rwanda to develop and roll out risk maps and 
decision support frameworks for RVF, thus reducing 
what could be huge economic and human health 
tolls from the increased outbreaks expected with 
climate change.  
The RVF risk maps and decision support framework 
have been successfully deployed in Kenya (Oyas et al. 
2018; Munyua et al. 2016) and are ready for roll out in 
other countries. The risk maps classify areas as high, 
medium or low risk. The decision support framework 
provides a roadmap for 1. Deciding where to establish 
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early warning in compliance with the WHO international 
health regulations; 2.  Setting up long-term disease prevention 
and control programs in livestock such as vaccination and 
public education; 3. Initiating mitigating actions in response to 
a forecasted epidemic; and 4. Raising the suspicion index and 
setting up appropriate diagnostics in human health facilities 
to look for cases during epidemic and inter-epidemic periods 
(Consultative group for RVF decision support 2010).   
In addition to further rolling out the RVF tools, ILRI will work 
in partnership with national, regional and international players 
to adapt these tools for other climate sensitive diseases.  
ILRI’s impact and capacity  
Strong research program in Animal and Human 
Health implemented by multidisciplinary teams of 
experienced and highly trained researchers specializing 
in epidemiology, immunology, biotechnology, diagnostics 
and One Health approaches. The teams operate in multiple 
countries in sub-Saharan Africa and Southeast Asia, working 
at country and regional levels to deliver critical analyses and 
tools to producers and policymakers.  
World class facilities for lab and field-based research and 
technology development, including Biosciences Eastern 
and Southern Africa (BecA), the ILRI Vaccine Platform 
(ILVAC), and Kapiti Ranch.  
Strong country level relationships across sub-Saharan 
Africa and Southeast Asia that open the door for 
capacity building efforts on disease surveillance and 
control.  
Lead institute globally researching RVF. Delivered critical 
RVF decision tools that are already helping policymakers 
confront the disease.  
Developed and deployed the ECF infect and treat 
method, with extensive and positive benefits for 
livestock farmers. In addition, ILRI is engaged in ongoing 
work on new vaccines for ECF and RVF as well as other sub-
unit vaccines and on several disease diagnostic tools.  
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